Ketchum Harmony C, Morganti Claudia, Yanase Chie, Ebert Blake, Ito Keisuke, Dawlaty Meelad M
Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research Albert Einstein College of Medicine Bronx New York USA.
Department of Genetics Albert Einstein College of Medicine Bronx New York USA.
Hemasphere. 2025 May 6;9(5):e70140. doi: 10.1002/hem3.70140. eCollection 2025 May.
The ten-eleven translocation family of enzymes (TET1/2/3) promotes DNA demethylation and is essential for hematopoiesis. While the roles of TET1 and TET2 are well-studied in hematopoiesis, the requirement of TET3 in embryonic and adult hematopoiesis is less investigated. In this study, by characterizing embryonic and adult hematopoiesis in ; mice, we have established a requirement for TET3 in regulating hematopoietic stem cells (HSCs; CD150CD48). We found that loss of TET3 in the fetal liver and adult bone marrow causes a reduction in the percent of long-term HSCs (LT-HSCs; CD150CD48CD34). This was accompanied by reduced colony forming capacity of TET3-deficient HSCs in vitro and reduced contribution of HSCs after a competitive bone marrow transplantation in vivo. TET3 deficiency increased DNA methylation at several cell cycle regulator genes leading to their down regulation. This is consistent with, and likely underpins, the reduced number of quiescent HSCs in TET3-deficient bone marrow. These findings uncover a new role for TET3 in HSC homeostasis during embryonic and adult hematopoiesis.
十一易位酶家族(TET1/2/3)促进DNA去甲基化,对造血过程至关重要。虽然TET1和TET2在造血过程中的作用已得到充分研究,但TET3在胚胎和成人造血过程中的需求研究较少。在本研究中,通过对Tet3基因敲除小鼠的胚胎和成人造血过程进行表征,我们确定了TET3在调节造血干细胞(HSCs;CD150+CD48-)中的需求。我们发现,胎儿肝脏和成人骨髓中TET3的缺失导致长期造血干细胞(LT-HSCs;CD150+CD48-CD34+)的百分比降低。这伴随着TET3缺陷型造血干细胞在体外的集落形成能力降低,以及在体内竞争性骨髓移植后造血干细胞的贡献减少。TET3缺陷增加了几个细胞周期调节基因的DNA甲基化,导致它们的下调。这与TET3缺陷骨髓中静止造血干细胞数量减少一致,并且可能是其基础。这些发现揭示了TET3在胚胎和成人造血过程中对造血干细胞稳态的新作用。